Creative Planning Cassava Sciences Inc Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Cassava Sciences Inc stock. As of the latest transaction made, Creative Planning holds 6,831 shares of SAVA stock, worth $18,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,831

Holding current value

$18,785

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$9.57 - $35.08 $65,372 - $239,631	6,831 New	6,831 $201,000
Q2 2023 Jul 21, 2023	BUY	$21.59 - $27.88 $24,288 - $31,365	1,125 Added 9.79%	12,616 $309,000
Q1 2023 May 15, 2023	SELL	$23.46 - $36.44 $34,791 - $54,040	-1,483 Reduced 11.43%	11,491 $277,000
Q4 2022 Feb 10, 2023	SELL	$27.82 - $44.16 $4,145 - $6,579	-149 Reduced 1.14%	12,974 $383,000
Q3 2022 Nov 03, 2022	BUY	$16.33 - $51.06 $11,724 - $36,661	718 Added 5.79%	13,123 $549,000
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $40,174 - $89,750	-2,333 Reduced 15.83%	12,405 $349,000
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $136,431 - $222,014	-4,185 Reduced 22.12%	14,738 $547,000
Q4 2021 Feb 11, 2022	BUY	$36.77 - $90.91 $27,577 - $68,182	750 Added 4.13%	18,923 $827,000
Q3 2021 Nov 10, 2021	BUY	$41.79 - $135.3 $759,449 - $2.46 Million	18,173 New	18,173 $1.13 Million
Q2 2021 Aug 04, 2021	SELL	$32.15 - $89.72 $594,710 - $1.66 Million	-18,498 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$7.09 - $87.95 $30,841 - $382,582	4,350 Added 30.75%	18,498 $831,000
Q4 2020 Jan 29, 2021	SELL	$6.79 - $12.25 $193,175 - $348,512	-28,450 Reduced 66.79%	14,148 $96,000
Q3 2020 Nov 05, 2020	BUY	$2.86 - $11.51 $59,917 - $241,134	20,950 Added 96.78%	42,598 $490,000
Q2 2020 Jul 23, 2020	BUY	$2.04 - $9.64 $17,034 - $80,494	8,350 Added 62.79%	21,648 $67,000
Q1 2020 May 05, 2020	BUY	$3.26 - $9.65 $43,351 - $128,325	13,298 New	13,298 $55,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

Black Rock Inc. New York, NY

3.22M
Shares

$8.85 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.52M
Shares

$6.94 Million
0.0% of portfolio
State Street Corp Boston, MA

1.16M
Shares

$3.2 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.01M
Shares

$2.77 Million
0.0% of portfolio
Gallacher Capital Management LLC Lone Tree, CO

580K
Shares

$1.6 Million
7.83% of portfolio

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account